Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2017 2
2018 1
2019 2
2020 2
2021 1
2022 3
2023 3
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
A scoping review finds a growing trend in studies validating multimorbidity patterns and identifies five broad types of validation methods.
Dhafari TB, Pate A, Azadbakht N, Bailey R, Rafferty J, Jalali-Najafabadi F, Martin GP, Hassaine A, Akbari A, Lyons J, Watkins A, Lyons RA, Peek N. Dhafari TB, et al. Among authors: azadbakht n. J Clin Epidemiol. 2024 Jan;165:111214. doi: 10.1016/j.jclinepi.2023.11.004. Epub 2023 Nov 11. J Clin Epidemiol. 2024. PMID: 37952700 Free article.
Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
Akthar M, Nair N, Carter LM, Vital EM, Sutton E, McHugh N; British Isles Lupus Assessment Group Biologics Register (BILAG BR) Consortium; MASTERPLANS Consortium; Bruce IN, Reynolds JA. Akthar M, et al. Arthritis Res Ther. 2023 Jun 30;25(1):111. doi: 10.1186/s13075-023-03089-5. Arthritis Res Ther. 2023. PMID: 37391799 Free PMC article.
Defining trajectories of response in patients with psoriasis treated with biologic therapies.
Geifman N, Azadbakht N, Zeng J, Wilkinson T, Dand N, Buchan I, Stocken D, Di Meglio P, Warren RB, Barker JN, Reynolds NJ, Barnes MR, Smith CH, Griffiths CEM, Peek N; BADBIR Study Group, on behalf of the PSORT Consortium. Geifman N, et al. Among authors: azadbakht n. Br J Dermatol. 2021 Oct;185(4):825-835. doi: 10.1111/bjd.20140. Epub 2021 Jun 4. Br J Dermatol. 2021. PMID: 33829489
15 results